A 2026 mouse study found that complete IL-6 deficiency worsened motor dysfunction and dopaminergic injury in MPTP and alpha-synuclein A53T Parkinson’s disease models, with earlier and broader vulnerability in female knockout mice.1 The result cuts against a simple “less inflammation is always better” frame: recombinant IL-6 partly improved MPTP-induced motor dysfunction and striatal dopaminergic terminal …
A Cell Reports study tied C9orf72-related ALS/FTD inflammation to a gut-bacterial product: inflammatory microbial glycogen appeared in 15 of 22 ALS fecal samples, 1 of 1 C9orf72-frontotemporal dementia sample, and 4 of 12 healthy controls.1 The result supports a narrower gene-by-microbial-product mechanism that makes C9orf72 loss of function more inflammatory. Research Highlights Human samples carried …
In APP/PS1 Alzheimer's model mice, deleting PTP1B or treating with the allosteric inhibitor DPM-1003 improved memory behavior, lowered amyloid burden, and pushed microglia toward SYK-driven clearance — a plausible mechanism, not a human treatment result yet.1 Research Highlights PTP1B loss improved behavior in APP/PS1 mice. Genetic deletion and DPM-1003 treatment improved novel object recognition and …
A 2026 mechanistic review linked microplastics to 6 proposed Alzheimer’s disease pathways and 6 proposed Parkinson’s disease pathways.1 The calibrated interpretation is that microplastics are biologically plausible brain stressors, but the human evidence does not yet prove that they cause Parkinson’s disease or Alzheimer’s disease. Research Highlights Exposure is widespread: the review cited an estimate …
A 2026 mouse study found that Theiler’s murine encephalomyelitis virus (TMEV) injected into the substantia nigra produced persistent Parkinson’s-like motor signals through 20 weeks, including apomorphine-induced rotations at every measured post-injection timepoint.1 The finding makes TMEV a useful viral-neuroinflammation model of dopamine-neuron injury, but it does not show that Theiler’s virus causes human Parkinson’s disease. …
A 2026 rat and astrocyte study found that human umbilical cord mesenchymal stem cell exosomes given 6 hours after experimental intracerebral hemorrhage reduced pro-inflammatory signaling and improved neurological recovery scores through the PI3K/AKT/PKM2/H3K18la pathway.1 The result is a mechanistic preclinical signal, not an emergency treatment for human brain hemorrhage. Research Highlights Exosomes were timed early: …
A 2026 review of electroacupuncture for depression found a familiar split: mechanistic evidence is rich, but clinical proof remains uneven because representative trials ranged from 65 to 270 participants, used different sham or drug comparators, and often failed to connect stimulation parameters with biological endpoints.1 Electroacupuncture is plausible as a subtype-matched neuromodulation strategy, but it …